Press release: CMB.TECH fleet updateGlobeNewsWire · Oct 13, 2026
CMB.TECH SPECIAL GENERAL MEETING RESULTSGlobeNewsWire · Oct 8, 2026
Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy DevelopmentPRNewsWire · Oct 8, 2026
INCY or TECH: Which Is the Better Value Stock Right Now?Zacks Investment Research · Sep 30, 2026
INTURAI PROVIDES DEFENCE TECH COMPETITION RESULTS AND COMPANY UPDATEPRNewsWire · Sep 29, 2026
Bio-Techne (NASDAQ:TECH) Reaches New 52-Week High – Time to Buy?Defense World · Sep 28, 2026Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 12, 2026 | $0.52 | $0.52 | Beat |
| May 6, 2026 | $0.55 | $0.53 | Miss |
| Feb 4, 2026 | $0.43 | $0.46 | Beat |
| Nov 5, 2025 | $0.42 | $0.42 | Miss |
| Aug 6, 2025 | $0.50 | $0.53 | Beat |
| May 7, 2025 | $0.51 | $0.56 | Beat |